Mark E. Bertels - 15 Nov 2022 Form 4 Insider Report for CORVEL CORP (CRVL)

Reporting relationship: EVP - Risk Management Services
Issuer ticker: CRVL
Reported as of: 15 Nov 2022
Net transaction value: -$189,450
SEC form: 4
Accepted by SEC: 18 Nov 2022, 10:22:07 UTC
Prior SEC filing: 07 Nov 2022
Next SEC filing: 09 Feb 2023
Source filing: View source filing
Reporting owner signature: By: Sharon O'Connor For: Mark Bertels

Key filing fact

Mark E. Bertels filed Form 4 for CORVEL CORP (CRVL) on 18 Nov 2022.

Key facts

This page summarizes Mark E. Bertels's Form 4 filing for CORVEL CORP (CRVL).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Nov 2022, 10:22.

Change

Previous filing in this sequence was filed on 07 Nov 2022.
Current net transaction value: -$189,450.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRVL transaction

Common Stock

Options Exercise

Transaction value: $40,050
Shares: +750
Change %: +88%
Price: $53.40^*
Shares after: 1,600
Date: 15 Nov 2022
Ownership: Direct

CRVL transaction

Common Stock

Sale

Transaction value: $114,750
Shares: -750
Change %: -47%
Price: $153.00
Shares after: 850
Date: 15 Nov 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVL transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value: $114,750
Shares: -750
Change %: -100%
Price: $153.00
Shares after: 0
Date: 15 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 750
Exercise price: $53.40
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .